Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 24532687)


A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression.

Okada N, Lin CP, Ribeiro MC, Biton A, Lai G, He X, Bu P, Vogel H, Jablons DM, Keller AC, Wilkinson JE, He B, Speed TP, He L.

Genes Dev. 2014 Mar 1;28(5):438-50. doi: 10.1101/gad.233585.113. Epub 2014 Feb 14.


miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

Kasinski AL, Slack FJ.

Cancer Res. 2012 Nov 1;72(21):5576-87. doi: 10.1158/0008-5472.CAN-12-2001. Epub 2012 Sep 10.


miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.

Wang DT, Ma ZL, Li YL, Wang YQ, Zhao BT, Wei JL, Qi X, Zhao XT, Jin YX.

Oncol Rep. 2013 Jul;30(1):492-8. doi: 10.3892/or.2013.2453. Epub 2013 May 13.


MiR-34, SIRT1 and p53: the feedback loop.

Yamakuchi M, Lowenstein CJ.

Cell Cycle. 2009 Mar 1;8(5):712-5. Epub 2009 Mar 2.


MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.

Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF.

Carcinogenesis. 2012 Mar;33(3):519-28. doi: 10.1093/carcin/bgr304. Epub 2011 Dec 22.


miR-34a repression of SIRT1 regulates apoptosis.

Yamakuchi M, Ferlito M, Lowenstein CJ.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6. doi: 10.1073/pnas.0801613105. Epub 2008 Aug 28.


p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.

Shi L, Jackstadt R, Siemens H, Li H, Kirchner T, Hermeking H.

Cancer Res. 2014 Jan 15;74(2):532-42. doi: 10.1158/0008-5472.CAN-13-2203. Epub 2013 Nov 27.


p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells.

Kim NH, Cha YH, Kang SE, Lee Y, Lee I, Cha SY, Ryu JK, Na JM, Park C, Yoon HG, Park GJ, Yook JI, Kim HS.

Cell Cycle. 2013 May 15;12(10):1578-87. doi: 10.4161/cc.24739. Epub 2013 Apr 25.


Small RNA combination therapy for lung cancer.

Xue W, Dahlman JE, Tammela T, Khan OF, Sood S, Dave A, Cai W, Chirino LM, Yang GR, Bronson R, Crowley DG, Sahay G, Schroeder A, Langer R, Anderson DG, Jacks T.

Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):E3553-61. doi: 10.1073/pnas.1412686111. Epub 2014 Aug 11.


miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress.

Xiao J, Lin H, Luo X, Luo X, Wang Z.

EMBO J. 2011 Feb 2;30(3):524-32. doi: 10.1038/emboj.2010.347. Epub 2011 Jan 7.


MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame.

Mandke P, Wyatt N, Fraser J, Bates B, Berberich SJ, Markey MP.

PLoS One. 2012;7(8):e42034. doi: 10.1371/journal.pone.0042034. Epub 2012 Aug 1.


Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M.

Mol Cell. 2007 Jun 8;26(5):731-43. Epub 2007 May 31.


p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M, Pilpel Y, Nielsen FC, Oren M, Lund AH.

Cell Death Differ. 2010 Feb;17(2):236-45. doi: 10.1038/cdd.2009.109. Epub 2009 Aug 21.


MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.

Wang LG, Ni Y, Su BH, Mu XR, Shen HC, Du JJ.

Int J Oncol. 2013 Mar;42(3):957-62. doi: 10.3892/ijo.2013.1767. Epub 2013 Jan 10.


MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.

Luan S, Sun L, Huang F.

Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007.


OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.

Ng WL, Chen G, Wang M, Wang H, Story M, Shay JW, Zhang X, Wang J, Amin AR, Hu B, Cucinotta FA, Wang Y.

Cell Death Dis. 2014 Jan 23;5:e1024. doi: 10.1038/cddis.2013.563.


Negative regulation of tumor suppressor p53 by microRNA miR-504.

Hu W, Chan CS, Wu R, Zhang C, Sun Y, Song JS, Tang LH, Levine AJ, Feng Z.

Mol Cell. 2010 Jun 11;38(5):689-99. doi: 10.1016/j.molcel.2010.05.027.


An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.

Wynendaele J, Böhnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, Sbrzesny N, Kubitza D, Wolf A, Gradhand E, Balschun K, Braicu I, Sehouli J, Darb-Esfahani S, Denkert C, Thomssen C, Hauptmann S, Lund A, Marine JC, Bartel F.

Cancer Res. 2010 Dec 1;70(23):9641-9. doi: 10.1158/0008-5472.CAN-10-0527. Epub 2010 Nov 16.


Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.

Amir S, Ma AH, Shi XB, Xue L, Kung HJ, Devere White RW.

PLoS One. 2013 Apr 9;8(4):e61064. doi: 10.1371/journal.pone.0061064. Print 2013.


miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis.

Adlakha YK, Saini N.

Cell Death Dis. 2013 Mar 14;4:e542. doi: 10.1038/cddis.2013.46.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk